← Leaderboards
Christopher Hartl
Epigenome Technologies, Inc.
$4,417,564
Attributed
$4,417,564
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,417,564 · 3
By mechanism
R44$3,918,089 · 2
R43$499,475 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposCellsMolecularEpigenomeGenetic TranscriptionHistone ModificationSamplingRegulatory ElementTechnologyGene Expression ProfileMultiple OmicsProgramsGene ExpressionGenesCell TypeProtocols DocumentationPublishingPersonsReagentEpigenetic ProcessDna MethylationDna-Binding ProteinsNext GenerationAntibodies
Grant awards (5)
Single-cell Epigenome Analysis of the Alzheimer's Disease Brain$964,766
R44 · FY2025 · AG · contact PI
Single-cell Epigenome Analysis of the Alzheimer's Disease Brain$995,100
R44 · FY2024 · AG · contact PI
High-throughput Single Cell Co-assay of Histone Modifications andTranscriptome$825,111
R44 · FY2024 · GM · contact PI
High-throughput Single Cell Co-assay of Histone Modifications andTranscriptome$1,133,112
R44 · FY2023 · GM · contact PI
Single-cell Epigenome Analysis of the Alzheimer's Disease Brain$499,475
R43 · FY2022 · AG · contact PI